Send to

Choose Destination
Mol Med Today. 1998 Apr;4(4):166-73.

Vaccines against Chlamydia: approaches and progress.

Author information

Antigen Presentation Research Group, Imperial College School of Medicine at Northwick Park Hospital, Harrow, Middlesex, UK.


Infections of the eye and genital tract with the bacterium Chlamydia trachomatis are a major cause of morbidity worldwide and are costly to treat. Development of a vaccine capable of protecting against infection or severe disease presents special challenges but would be the most effective long-term option for control of chlamydial disease. Progress has been made in understanding protective and pathological immune mechanisms in these infections, and a number of potential vaccine candidates have been developed.

[Indexed for MEDLINE]

Supplemental Content

Loading ...
Support Center